Results 31 to 40 of about 65,038 (202)

Study of immunophenotypic markers and clinico-hematological findings in chronic lymphocytic leukemia

open access: yesZanco Journal of Medical Sciences, 2023
Background and objective: Chronic lymphocytic leukemia (CLL) is a clonal, mature B-cell neoplasm, its clinical features, cell morphology, and immunophenotyping are used to establish the diagnosis.
Ansam Mazin Butrous   +1 more
doaj   +1 more source

Burnout en el personal del área de salud y estrategias de afrontamiento

open access: yesCorreo Científico Médico, 2020
El burnout es un síndrome psicológico caracterizado por la presencia de manifestaciones sugestivas de agotamiento emocional, despersonalización y baja realización personal.
Diana Sofia Serna Corredor   +1 more
doaj  

Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia. [PDF]

open access: yes, 2017
BackgroundThe CXCR4-CXCL12 axis plays an important role in the chronic lymphocytic leukemia (CLL)-microenvironment interaction. Overexpression of CXCR4 has been reported in different hematological malignancies including CLL.
Amaya-Chanaga, Carlos I   +18 more
core   +4 more sources

The Elevation and Impact of Peripheral Bile Acids in Chronic Lymphocytic Leukemia

open access: yesBiomedicines
Background: Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western world. Targeted therapies have made CLL manageable for many patients, but the ongoing threat of disease relapse or transformation beckons a deeper ...
Audrey L. Smith   +7 more
doaj   +1 more source

Chemotactic Cues for NOTCH1-Dependent Leukemia [PDF]

open access: yes, 2018
The NOTCH signaling pathway is a conserved signaling cascade that regulates many aspects of development and homeostasis in multiple organ systems.
Amadori, Alberto   +3 more
core   +1 more source

Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis

open access: yesJournal of Nanobiotechnology, 2007
B-Chronic Lymphocytic Leukemia (CLL) is an incurable disease predominantly characterized by apoptosis resistance. We have previously described a VEGF signaling pathway that generates apoptosis resistance in CLL B cells.
Lu Lichun   +11 more
doaj   +1 more source

Comparative genomic hybridization and amplotyping by arbitrarily primed PCR in stage A B-CLL [PDF]

open access: yes, 2001
Cytogenetic analysis is useful in the diagnosis and to assess prognosis of B-cell chronic lymphocytic leukemia (B-CLL). However, successful cytogenetics by standard techniques has been hindered by the low in vitro mitotic activity of the malignant B-cell
Ardanaz, M.T. (M.T.)   +10 more
core   +1 more source

MOLEKULARNA DIJAGNOSTIKA B-CLL

open access: yesLiječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 2007
B - kronična limfocitna leukemija (B-CLL) je neoplazma malih B-limfocita koji infiltriraju perifernu krv, koštanu srž, limfne čvorove, a katkad i parenhimatozne organe. Osim tipičnih biljega perifernih B limfocita u većini slučajeva eksprimiraju CD5 i CD23.
Korać, Petra, Dominis, Marija
openaire   +2 more sources

The Role of Tumor Necrosis Factor and ITS Soluble Receptors in Myelosuppression Developing in B-Cell Chronic Lymphocytic Leukemia

open access: yesЛьвівський клінічний вісник, 2015
Introduction. Myelosuppression with severe anemia or thrombocytopenia refers to the adverse factors in clinical course of B-cell chronic lymphocytic leukemia (B-CLL).
Barilka V.   +4 more
doaj   +1 more source

Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis [PDF]

open access: yesLeukemia, 2001
Malignant B cells from chronic lymphocytic leukemia (B-CLL) patients have a long survival in vivo, although, in culture, they spontaneously die by apoptosis. Here, we analyzed the capacity of accessory leukocytes to modulate apoptosis of B-CLL cells in vitro.
Gamberale, Romina   +7 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy